文献速递新生儿儿童感染

早产儿宫内暴露利妥昔单抗后发生脓毒症发作

Septic Episodes in a Premature Infant After In Utero Exposure to Rituximab.
PubMed 文献 · Pediatrics · 2017-08-02

本文报告一例29周胎龄、出生体重820g的早产儿,在宫内暴露于利妥昔单抗后发生两次由粪肠球菌引起的严重脓毒症发作。患儿在37周矫正胎龄时B淋巴细胞亚群严重降低至10%,IgG、IgM和IgA均检测不到。两次脓毒症均与从捐赠人乳过渡到配方奶喂养的时间重合,提示胎盘转移利妥昔单抗、早产和低水平保护性母源抗体可能增加其对粪肠球菌的易感性。

要点

  • 宫内暴露利妥昔单抗的早产儿可能出现严重B细胞减少和免疫球蛋白缺失。
  • 此类患儿发生由正常肠道菌群(如粪肠球菌)引起的严重脓毒症风险可能增加。
  • 捐赠人乳中的分泌型IgA可能对这类患儿具有保护作用。

核心结论

  • 宫内暴露利妥昔单抗可能与早产儿严重脓毒症发作相关,尤其当合并早产和低母源抗体时。

研究设计与样本

  • 本文为单例病例报告,描述一例29周胎龄、出生体重820g的早产儿宫内暴露利妥昔单抗后的临床过程。

主要发现

  • 患儿发生两次由粪肠球菌引起的严重脓毒症发作,两次均与从捐赠人乳过渡到配方奶喂养的时间重合。
  • 在37周矫正胎龄时,患儿B淋巴细胞亚群严重降低至10%,IgG、IgM和IgA均检测不到。
  • 患儿接受了静脉注射免疫球蛋白、抗生素和捐赠人乳治疗。

关键数值与推荐

  • 在37周矫正胎龄时,B淋巴细胞亚群为10%,IgG、IgM和IgA检测不到。

临床怎么用

  • 对宫内暴露利妥昔单抗的早产儿应警惕免疫抑制和严重脓毒症风险,监测B细胞和免疫球蛋白水平。
  • 喂养方式转换(如从捐赠人乳到配方奶)可能与脓毒症发作相关,需加强监测。
  • 捐赠人乳中的分泌型IgA可能具有保护作用,可考虑用于此类患儿。

局限性

  • 本文为单例病例报告,无法确立因果关系,结论需更大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rituximab is an increasingly used immunotherapeutic agent for women of reproductive age for treatment of autoimmune diseases, leukemias, and lymphomas. Rituximab is a chimeric monoclonal antibody that targets B-cell surface antigen CD20 and can cross the placenta. Current evidence of the impact of this medication on the developing fetus is limited, but there is little to suggest that fetal exposure to this medication places an infant at increased risk of immunosuppression and subsequent infection. Here we report a case of in utero rituximab exposure that was associated with 2 severe septic episodes with Enterococcus faecalis, in a premature infant of 29 weeks' gestational age with a birth weight of 820 g. The patient had a critically depressed B-lymphocyte subset of 10% and undetectable immunoglobulin (Ig)G, IgM, and IgA levels at 37 weeks' postmenstrual age. Interestingly, both episodes of sepsis coincided with transition from donor human milk to formula feeds. She was treated with intravenous immunoglobulin, antibiotics, and donor human milk. We postulate that placental transfer of rituximab, prematurity, and the low levels of protective maternal antibodies increased the susceptibility of this patient to sepsis by E faecalis, a resident of the normal gut flora, whereas the secretory IgA in donor human milk may have played a protective role.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Hay S, Burchett S, Odejide O, et al. Septic Episodes in a Premature Infant After In Utero Exposure to Rituximab. Pediatrics. 2017. PMID: 28768852. doi:10.1542/peds.2016-2819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。